Sfoglia per Autore  

Opzioni
Mostrati risultati da 41 a 60 di 84
Titolo Anno di pubblicazione Autori Unitn File
Inherited determinants of early recurrent somatic mutations in prostate cancer 1-gen-2017 Romanel, AlessandroGarritano, SoniaStringa, BlertaDalfovo, DavidePetris, GianlucaGasperini, PaolaCereseto, AnnaSboner, AndreaInga, AlbertoDemichelis, Francesca +
EthSEQ: ethnicity annotation from whole exome sequencing data 1-gen-2017 Romanel, AlessandroDemichelis, Francesca +
Exome sequencing of African-American prostate cancer reveals loss-of-function ERF mutations 1-gen-2017 Romanel, AlessandroDemichelis, Francesca +
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study 1-gen-2017 Romanel, AlessandroDemichelis, Francesca +
Hit and go CAS9 delivered through a lentiviral based self-limiting circuit 1-gen-2017 Petris, GianlucaCasini, AntonioMontagna, ClaudiaLorenzin, FrancescaPrandi, DavideRomanel, AlessandroZasso, JacopoConti, LucianoDemichelis, FrancescaCereseto, Anna
A highly specific SpCas9 variant is identified by in vivo screening in yeast 1-gen-2018 Casini, AntonioPetris, GianlucaMontagna, ClaudiaMaule, GiuliaLorenzin, FrancescaPrandi, DavideRomanel, AlessandroDemichelis, FrancescaInga, AlbertoCereseto, Anna +
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer 1-gen-2019 Romanel, AlessandroDemichelis, FrancescaSboner, Andrea +
Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations 1-gen-2019 Casiraghi N.Benelli M.Romanel A.Demichelis F. +
PaCBAM: Fast and scalable processing of whole exome and targeted sequencing data 1-gen-2019 Valentini S.Fedrizzi T.Demichelis F.Romanel A.
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 1-gen-2019 Romanel A. +
Allele-specific expression analysis in cancer using next-generation sequencing data 1-gen-2019 Romanel A.
RB1 heterogeneity in advanced metastatic castration-resistant prostate cancer 1-gen-2019 Casiraghi N.Romanel A.Gasperini P.Demichelis F. +
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers 1-gen-2019 Romanel A.Sboner A.Prandi D.Demichelis F. +
Truncated BRPF1 Cooperates with Smoothened to Promote Adult Shh Medulloblastoma 1-gen-2019 Aiello G.Ballabio C.Fagnocchi L.Anderle M.Caron D.Garilli F.Piazza S.Romanel A.Zippo A.Tiberi L. +
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes 1-gen-2020 Romanel, AlessandroDemichelis, FrancescaSboner, Andrea +
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer 1-gen-2020 Romanel A.Demichelis F. +
Inherited variant in NFκB‐1 promoter is associated with increased risk of IBD in an Algerian population and modulates SOX9 binding 1-gen-2020 Hamadou, ImeneGarritano, SoniaRomanel, AlessandroDemichelis, Francesca +
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer 1-gen-2020 Romanel A.Casiraghi N.Franceschini G. M.Orlando F.Fedrizzi T.Sboner A.Benelli M.Demichelis F. +
Exploring functionally annotated transcriptional consensus regulatory elements with CONREL 1-gen-2020 Dalfovo, DavideValentini, SamuelRomanel, Alessandro
Ancestry-specific predisposing germline variants in cancer 1-gen-2020 Romanel, AlessandroDemichelis, Francesca +
Mostrati risultati da 41 a 60 di 84
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile